INCY News & Events

Incyte and Genesis Molecular AI announced a significant expansion of their strategic collaboration building and deploying AI to accelerate the discovery of novel molecules for collaboration targets selected by Incyte. The expanded agreement is among the first major pharma-AI collaborations to power large-scale foundation model training with a partner's proprietary experimental data.

Incyte and Edison Scientific announced a strategic collaboration to employ Kosmos, Edison's AI scientist, for Incyte's discovery and development work. Kosmos will be embedded across the Incyte discovery and development lifecycle, enabling continuous learning from translational and clinical data, real-time synthesis of evidence and predictive models of therapeutic performance.